Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics tags : Collaboration save search
Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
VYGR | $7.5 -0.66% -0.67% 520K
|
Health Technology
|
| O: 0.48%
H: 0.24%
C: -4.77%
SGMO | $0.5143 6.02% 5.68% 1M
|
Health Technology
|
| O: 3.13%
H: 0.38%
C: -2.68%
NBIX M | $132.03 -0.39% -0.39% 560K
|
Health Technology
|
| O: -2.15%
H: 2.58%
C: 0.92%
candidate payment for collaboration program therapeutics milestone
Rallybio Announces Collaboration to Advance Therapeutic Solutions for Pregnant Individuals at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
Published: 2024-04-10 (Crawled : 22:00) - biospace.com/
RLYB | News | $1.75 4.79% 4.57% 310K
|
|
| O: -3.03%
H: 4.38%
C: 1.87%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: 0.0%
risk solutions for collaboration
Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
Published: 2024-04-09 (Crawled : 13:00) - biospace.com/
CRL | $226.78 -0.34% 0.0% 410K
|
Commercial Services
|
| O: 0.93%
H: 0.36%
C: -0.05%
rare disease collaboration therapeutics therapy
Nurix Therapeutics Announces Extension of Strategic Collaboration with Sanofi to Develop Novel Targeted Protein Degraders of STAT6
Published: 2024-04-09 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.38%
H: 0.95%
C: 0.83%
NRIX 3 d | $13.6 -5.82% -6.18% 1M
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
protein collaboration extension therapeutics sanofi
Aethon Therapeutics Announces Collaboration with Revolution Medicines to Discover and Develop Novel Aethon Antibody Programs
Published: 2024-04-04 (Crawled : 19:00) - biospace.com/
RVMD S | $34.95 -2.46% -2.52% 1.2M
|
Health Technology
|
| O: 0.67%
H: 1.8%
C: -4.62%
antibody collaboration therapeutics
Odyssey Therapeutics Announces Strategic Collaboration to Advance AI-Driven Small Molecule Drug Discovery
Published: 2024-04-04 (Crawled : 19:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.51%
H: 0.0%
C: 0.0%
drug collaboration therapeutics
CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas
Published: 2024-04-03 (Crawled : 12:00) - globenewswire.com
CTMX | $1.67 -3.47% -3.59% 510K
|
Health Technology
|
| O: -0.47%
H: 2.35%
C: 0.94%
probody candidate t-cell collaboration therapeutics
Nurix Therapeutics Announces Extension of Strategic Collaboration with Gilead Sciences
Published: 2024-04-02 (Crawled : 12:00) - biospace.com/
NRIX 3 d | $13.6 -5.82% -6.18% 1M
|
Health Technology
|
| O: -1.59%
H: 6.37%
C: 4.57%
sciences collaboration extension therapeutics
Altamira Therapeutics Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccines
Published: 2024-03-25 (Crawled : 13:00) - globenewswire.com
CYTO | $1.5 -7.95% 46K
|
Manufacturing
|
| O: 83.24%
H: 10.09%
C: -25.87%
mrna group collaboration therapeutics
CytomX Therapeutics Announces Milestone Achievement in PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas - March 18, 2024
Published: 2024-03-18 (Crawled : 16:00) - biospace.com/
CTMX | $1.67 -3.47% -3.59% 510K
|
Health Technology
|
| O: 0.97%
H: 0.48%
C: -3.35%
probody t-cell collaboration therapeutics milestone
CytomX Therapeutics Announces Milestone Achievement in PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas
Published: 2024-03-18 (Crawled : 12:00) - globenewswire.com
CTMX | $1.67 -3.47% -3.59% 510K
|
Health Technology
|
| O: 0.97%
H: 0.48%
C: -3.35%
probody collaboration therapeutics milestone
Protagonist Therapeutics Announces Closing of Worldwide Rusfertide License and Collaboration Agreement with Takeda
Published: 2024-03-18 (Crawled : 12:00) - biospace.com/
PTGX | $25.61 1.55% 1.52% 450K
|
Health Technology
|
| O: -0.59%
H: 1.42%
C: -1.21%
license worldwide collaboration therapeutics agreement
Perspective Therapeutics Announces Clinical Collaboration Agreement with Bristol Myers Squibb to Evaluate [(212)Pb]VMT01 in Combination with Nivolumab in MC1R-Positive Metastatic Melanoma
Published: 2024-03-18 (Crawled : 12:00) - globenewswire.com
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.46%
H: 0.23%
C: -1.88%
vmt01 melanoma nivolumab collaboration therapeutics agreement
Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration
Published: 2024-03-14 (Crawled : 12:30) - biospace.com/
CRL | $226.78 -0.34% 0.0% 410K
|
Commercial Services
|
| O: 0.0%
H: 1.41%
C: -0.26%
collaboration therapeutics therapy
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Against Critical Oncogenic Proteins
Published: 2024-03-04 (Crawled : 12:00) - globenewswire.com
CCCC | $6.74 -2.46% -2.52% 1.7M
|
Health Technology
|
| O: 7.83%
H: 0.25%
C: -9.87%
merck research collaboration therapeutics
CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair
Published: 2024-03-04 (Crawled : 10:00) - globenewswire.com
GDTC | $2.125 1.68% 1.65% 3.8K
|
|
| O: 3.18%
H: 0.44%
C: -1.41%
cartilage hospital research collaboration therapeutics
Voyager Therapeutics Announces Selection of Gene Therapy Development Candidate for Friedreich’s Ataxia in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment
Published: 2024-02-26 (Crawled : 12:00) - globenewswire.com
VYGR | $7.5 -0.66% -0.67% 520K
|
Health Technology
|
| O: 2.2%
H: 5.62%
C: 3.35%
SGMO | $0.5143 6.02% 5.68% 1M
|
Health Technology
|
| O: 0.88%
H: 0.88%
C: -1.75%
NBIX M | $132.03 -0.39% -0.39% 560K
|
Health Technology
|
| O: 0.05%
H: 1.45%
C: 0.99%
candidate payment collaboration therapeutics therapy milestone
Silence Therapeutics Achieves $10 Million Milestone Payment from AstraZeneca Collaboration Following the Initiation of Phase 1 Trial
Published: 2024-02-23 (Crawled : 21:00) - biospace.com/
SLNCF | $8.0 -65.0% 630
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
SLN | $22.75 3.32% 3.21% 310K
|
Health Technology
|
| O: 3.34%
H: 2.83%
C: -1.59%
million payment astrazeneca collaboration trial therapeutics milestone
Intellia Therapeutics and ReCode Therapeutics Announce Strategic Collaboration to Develop Novel Gene Editing Therapies for Cystic Fibrosis
Published: 2024-02-15 (Crawled : 12:30) - globenewswire.com
NTLA | $21.57 1.17% 1.16% 1.4M
|
Health Technology
|
| O: -1.17%
H: 5.15%
C: 1.86%
fibrosis collaboration therapeutics
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
Published: 2024-02-08 (Crawled : 11:00) - globenewswire.com
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.16%
H: 0.17%
C: -1.16%
AUTL | $4.51 -6.04% -6.43% 1.4M
|
Health Technology
|
| O: 2.85%
H: 0.0%
C: -7.69%
pipeline cell collaboration car-t therapy
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.